Cargando…

Head injury is associated with tau deposition on PET in MCI and AD patients

INTRODUCTION: Head injuries (HI) are a risk factor for dementia, but the underlying etiology is not fully known. Understanding whether tau might mediate this relationship is important. METHODS: Cognition and tau deposition were compared between 752 individuals with (impaired, n = 302) or without cog...

Descripción completa

Detalles Bibliográficos
Autores principales:	Risacher, Shannon L., West, John D., Deardorff, Rachael, Gao, Sujuan, Farlow, Martin R., Brosch, Jared R., Apostolova, Liana G., McAllister, Thomas W., Wu, Yu‐Chien, Jagust, William J., Landau, Susan M., Weiner, Michael W., Saykin, Andrew J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Neuroimaging
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8383323/ https://www.ncbi.nlm.nih.gov/pubmed/34466653 http://dx.doi.org/10.1002/dad2.12230

Ejemplares similares

Olfactory identification in subjective cognitive decline and mild cognitive impairment: Association with tau but not amyloid positron emission tomography
por: Risacher, Shannon L., et al.
Publicado: (2017)

White matter alterations in early-stage Alzheimer's disease: A tract-specific study
por: Wen, Qiuting, et al.
Publicado: (2019)

Visual contrast sensitivity is associated with the presence of cerebral amyloid and tau deposition
por: Risacher, Shannon L, et al.
Publicado: (2020)

Memory concerns in the early Alzheimer's disease prodrome: Regional association with tau deposition
por: Swinford, Cecily G., et al.
Publicado: (2018)

Added value of amyloid PET in individualized risk predictions for MCI patients
por: van Maurik, Ingrid S., et al.
Publicado: (2019)

The effect of the top 20 Alzheimer disease risk genes on gray-matter density and FDG PET brain metabolism
por: Stage, Eddie, et al.
Publicado: (2016)

Evaluation of a visual interpretation method for tau‐PET with (18)F‐flortaucipir
por: Sonni, Ida, et al.
Publicado: (2020)

Genetic analysis of quantitative phenotypes in AD and MCI: imaging, cognition and biomarkers
por: Shen, Li, et al.
Publicado: (2013)

White matter changes in empirically derived incident MCI subtypes in the Mayo Clinic Study of Aging
por: Machulda, Mary M., et al.
Publicado: (2021)

Tau-related white-matter alterations along spatially selective pathways
por: Wen, Qiuting, et al.
Publicado: (2020)

Role of tau deposition in early cognitive decline in Down syndrome
por: Hartley, Sigan L., et al.
Publicado: (2022)

Baseline MRI Predictors of Conversion from MCI to Probable AD in the ADNI Cohort
por: Risacher, Shannon L, et al.
Publicado: (2009)

Cortical atrophy and amyloid and tau deposition in Down syndrome: A longitudinal study
por: Padilla, Concepcion, et al.
Publicado: (2022)

Plasma amyloid beta levels are associated with cerebral amyloid and tau deposition
por: Risacher, Shannon L., et al.
Publicado: (2019)

Heterogeneity of Tau Deposition and Microvascular Involvement in MCI and AD
por: Bryant, Annie G., et al.
Publicado: (2021)

Untangling tau imaging
por: Villemagne, Victor L., et al.
Publicado: (2016)

Longitudinal trajectories of amyloid deposition, cortical thickness, and tau in Down syndrome: A deep-phenotyping case report
por: Mak, Elijah, et al.
Publicado: (2019)

Amyloid duration is associated with preclinical cognitive decline and tau PET
por: Koscik, Rebecca L., et al.
Publicado: (2020)

In vivo coupling of tau pathology and cortical thinning in Alzheimer's disease
por: Mak, Elijah, et al.
Publicado: (2018)

Tau pathology in cognitively normal older adults
por: Ziontz, Jacob, et al.
Publicado: (2019)

Machine learning of brain structural biomarkers for Alzheimer's disease (AD) diagnosis, prediction of disease progression, and amyloid beta deposition in the Japanese population
por: Shiino, Akihiko, et al.
Publicado: (2021)

Critical review of the Appropriate Use Criteria for amyloid imaging: Effect on diagnosis and patient care
por: Apostolova, Liana G., et al.
Publicado: (2016)

Expanding the phenotypic associations of globular glial tau subtypes
por: Burrell, James R., et al.
Publicado: (2016)

Hippocampal subfield imaging and fractional anisotropy show parallel changes in Alzheimer's disease tau progression using simultaneous tau‐PET/MRI at 3T
por: Carlson, Mackenzie L., et al.
Publicado: (2021)

Regional tau deposition and subregion atrophy of medial temporal structures in early Alzheimer's disease: A combined positron emission tomography/magnetic resonance imaging study
por: Sone, Daichi, et al.
Publicado: (2017)

Cerebrovascular stiffness and flow dynamics in the presence of amyloid and tau biomarkers
por: Rivera‐Rivera, Leonardo A., et al.
Publicado: (2021)

Association between neurite metrics and tau/inflammatory pathology in Alzheimer's disease
por: Sone, Daichi, et al.
Publicado: (2020)

Deep learning improves utility of tau PET in the study of Alzheimer's disease
por: Zou, James, et al.
Publicado: (2021)

CSF glucose tracks regional tau progression based on Alzheimer's disease risk factors
por: Pappas, Colleen, et al.
Publicado: (2020)

In vivo network models identify sex differences in the spread of tau pathology across the brain
por: Shokouhi, Sepideh, et al.
Publicado: (2020)

Tau PET following acute TBI: Off-target binding to blood products, tauopathy, or both?
por: Butler, Tracy, et al.
Publicado: (2022)

Peri‐arterial pathways for clearance of α‐Synuclein and tau from the brain: Implications for the pathogenesis of dementias and for immunotherapy
por: Nimmo, Jacqui, et al.
Publicado: (2020)

Subjective memory complaints, cortical thinning, and cognitive dysfunction in middle-age adults at risk of AD
por: Schultz, Stephanie A., et al.
Publicado: (2015)

Staging of amyloid β, t-tau, regional atrophy rates, and cognitive change in a nondemented cohort: Results of serial mediation analyses
por: Fletcher, Evan, et al.
Publicado: (2018)

The role of apolipoprotein E (APOE) genotype in early mild cognitive impairment (E-MCI)
por: Risacher, Shannon L., et al.
Publicado: (2013)

Cross-Sectional and Longitudinal Hippocampal Atrophy, Not Cortical Thinning, Occurs in Amyloid-Negative, p-Tau-Positive, Older Adults With Non-Amyloid Pathology and Mild Cognitive Impairment
por: Rane Levendovszky, Swati
Publicado: (2022)

Detection of tau in Gerstmann-Sträussler-Scheinker disease (PRNP F198S) by [(18)F]Flortaucipir PET
por: Risacher, Shannon L., et al.
Publicado: (2018)

Comparison of Pittsburgh compound B and florbetapir in cross-sectional and longitudinal studies
por: Su, Yi, et al.
Publicado: (2019)

Association of the top 20 Alzheimer's disease risk genes with [(18)F]flortaucipir PET
por: Stage, Eddie, et al.
Publicado: (2022)

Multimodal neuroimaging study of cerebrovascular disease, amyloid deposition, and neurodegeneration in Alzheimer's disease progression
por: Lao, Patrick J., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_2bbgbsa20t6ais5o5jqj31tfke